TMEM126B
protein-codingtransmembrane protein 126B, the group of Mitochondrial complex I assembly complex
Gene summary
This gene encodes a mitochondrial transmembrane protein which is a component of the mitochondrial complex I assembly complex. The encoded protein serves as an assembly factor that is required for formation of the membrane arm of the complex. It interacts with NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 13. Naturally occurring mutations in this gene are associated with isolated complex I deficiency. A pseudogene of this gene has been defined on chromosome 9. [provided by RefSeq, Apr 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032633
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032633
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *TMEM126B* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of March 7, 2022. The *TMEM126B* gene encodes transmembrane protein 126B, which is a chaperone protein involved in the assembly of mitochondrial complex I. Defects of this protein lead to complex I deficiency, with variable onset of disease from soon after birth to adulthood. The* TMEM126B* gene was first reported in relation to primary mitochondrial disease in 2016 (PMID: 27374773). While various names have been given to the constellation of features seen in those with *TMEM126B*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *TMEM126B* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included four unique variants (2 missense, 1 frameshift, 1 stop-gained) identified in nine unrelated cases from four publications (PMIDs: 27374773, 27374774, 27290639, 29093663). The mechanism of pathogenicity appears to be loss of function. Of note, the c.635G>T (p.Gly212Val) variant, a proposed founder variant, has been identified in every case reported to date. This gene-disease relationship is also supported by a biochemical function shared with other genes associated with primary mitochondrial disease, functional alteration studies in patient and non-patient cells showing impaired mitochondrial function due to variants or gene knockdown, and rescue of the mitochondrial dysfunction in patient cells following expression of the wildtype protein (PMIDs: 27374773, 27374774, 29093663, 27977873, 22982022). In summary, there is definitive evidence to support the relationship between *TMEM126B* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on March 7, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0032633
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032633
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: Among other findings, individuals have been described with hypertrophic cardiomyopathy, and awareness may allow prompt diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TMEM126B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018480.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 17 | ||||
| missense | 2 | 50 | 12 | 1 | 65 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 5 | 8 | 13 | |||
| splice donor/acceptor (+/-2bp) | 3 | 2 | 5 | |||
| Total | 7 | 13 | 52 | 29 | 1 | 102 |
Highest pathogenic variant AF is 0.0014366546
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060950.3 | 5 | MANE Select | |
| Ensembl | ENSP00000351737.7 | 5 | MANE Select | |
| RefSeq | NP_001180466.1 | 5 | Standard | |
| RefSeq | NP_001180467.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Respiratory electron transport
- The citric acid (TCA) cycle and respiratory electron transport
- Metabolism
- Complex I biogenesis
- Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
Biological Process
- biological_process
- mitochondrial respiratory chain complex I assembly
Molecular Function
- molecular_function
- protein binding
Cellular Component
- cellular_component
- mitochondrion
- mitochondrial inner membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000358867
- Coding exons
- 5
- Length
- 7952
- Individuals with no LoFs
- 124797
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 41
- Defined
- 124838
- p
- 0.000164
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.179 | 128 | 122 | 1.05 | 0.00000585 | 1502 |
| Missense (PolyPhen) | 22 | 29.521 | 0.74524 | 406 | ||
| Synonymous | 0.224 | 40 | 41.8 | 0.956 | 0.00000209 | 440 |
| Loss of Function | 0.338 | 6 | 6.96 | 0.862 | 2.87e-7 | 110 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.00099 | notable |
| Latino/Admixed American | 0.00016 | 0.00015 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.000028 | 0.000026 | rare |
| South Asian | 0.00065 | 0.00050 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Chaperone protein involved in the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). Participates in constructing the membrane arm of complex I. {ECO:0000269|PubMed:24191001}.;
Recessive Scores
- pRec
- 0.0730
Intolerance Scores
- LoFtool
- 0.918
- RVIS EVS
- 0.39
- RVIS percentile EVS
- 76.05
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0656
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |